000			02096 a2200649 4500
005			20250516043249.0
264		0	_c20111017
008			201110s 0 0 eng d
022			_a1365-2036
024	7		_a10.1111/j.1365-2036.2011.04750.x _2doi
040			_aNLM _beng _cNLM
100	1		_aSun, J
245	0	0	_aRandomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance. _h[electronic resource]
260			_bAlimentary pharmacology & therapeutics _cAug 2011
300			_a424-31 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdenine _xanalogs & derivatives
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aChina
650	0	4	_aDrug Resistance, Viral _xdrug effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHepatitis B, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrganophosphonates _xtherapeutic use
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aRecombinant Proteins
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aHou, J-L
700	1		_aXie, Q
700	1		_aLi, X-H
700	1		_aZhang, J-M
700	1		_aWang, Y-M
700	1		_aWang, H
700	1		_aLai, J-Y
700	1		_aChen, S-J
700	1		_aJia, J-D
700	1		_aSheng, J-F
700	1		_aChan, H L Y
700	1		_aWang, J-F
700	1		_aLi, M K K
700	1		_aJiang, M
700	1		_aPopescu, M
700	1		_aSung, J J Y
773	0		_tAlimentary pharmacology & therapeutics _gvol. 34 _gno. 4 _gp. 424-31
856	4	0	_uhttps://doi.org/10.1111/j.1365-2036.2011.04750.x _zAvailable from publisher's website
999			_c20947030 _d20947030